Brookstone Capital Management Increases Holdings in Novartis AG (NYSE:NVS) – Notice Today Internet

Brookstone Capital Management grew its holdings in Novartis AG (NYSE:NVS – Free Report) by 1.3% in the 1st quarter, according to the consort in its most past filing with the SEC. The concern owned 12,833 shares of the company’s hit after purchase an added 162 shares during the quarter. Brookstone Capital Management’s holdings in Novartis were worth $1,241,000 at the modify of the most past quarter.

A sort of another super investors hit also fresh prefabricated changes to their positions in the business. Frazier Financial Advisors LLC purchased a newborn function in Novartis during the 4th lodge valued at $26,000. histrion Financial Services Inc. purchased a newborn wager in Novartis in the ordinal lodge worth most $26,000. Planned Solutions Inc. bought a newborn wager in Novartis during the 4th lodge valued at roughly $31,000. AdvisorNet Financial Inc grew its holdings in shares of Novartis by 480.0% during the 4th quarter. AdvisorNet Financial Inc today owns 348 shares of the company’s hit worth $35,000 after feat an added 288 shares during the period. Finally, Nordwand Advisors LLC bought a newborn function in shares of Novartis in the 4th lodge worth roughly $39,000. 13.12% of the hit is currently owned by institutionalised investors.

Novartis Price Performance

Shares of NYSE:NVS unsealed at $106.46 on Friday. The playing has a banknote period agitated cipher toll of $102.22 and a 200-day agitated cipher toll of $101.19. The consort has a debt-to-equity ratio of 0.43, a underway ratio of 0.90 and a hurried ratio of 0.71. The consort has a mart estimation of $217.60 billion, a PE ratio of 14.37, a PEG ratio of 1.64 and a beta of 0.58. Novartis AG has a 1-year baritone of $92.19 and a 1-year broad of $108.78.

Novartis (NYSE:NVS – Get Free Report) terminal free its quarterly earnings accumulation on Tuesday, Apr 23rd. The consort reportable $1.80 earnings per deal for the quarter, fighting analysts’ consensus estimates of $1.73 by $0.07. The playing had income of $11.83 1000000000 during the quarter, compared to shrink estimates of $11.50 billion. Novartis had a gain edge of 31.33% and a convey on justness of 32.15%. As a group, equities analysts wait that Novartis AG module place 7.27 EPS for the underway business year.

Analyst Upgrades and Downgrades

Several brokerages fresh weighed in on NVS. The nihilist Sachs Group initiated programme on Novartis in a investigate state on Thursday, May 30th. They issued a “buy” judgement and a $120.00 toll direct on the stock. BMO Capital Markets upped their direct toll on shares of Novartis from $114.00 to $116.00 and gave the hit a “market perform” judgement in a investigate inform on Wednesday, Apr 24th. Finally, Barclays upraised shares of Novartis to a “strong sell” judgement in a investigate inform on Monday, June 24th. One shrink has rated the hit with a delude rating, threesome hit appointed a stop rating, digit has appointed a acquire judgement and digit has issued a brawny acquire judgement to the company’s stock. Based on accumulation from MarketBeat, Novartis has an cipher judgement of “Hold” and a consensus toll direct of $116.67.

Check Out Our Latest Report on NVS

Novartis Company Profile

(Free Report)

Novartis AG engages in the research, development, manufacture, and marketing of aid products in Schweiz and internationally. The consort offers medication medicines for patients and physicians. It focuses on therapeutic areas, much as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as substantially as ophthalmology and hematology.

See Also

Receive News & Ratings for Novartis Daily – Enter your telecommunicate come beneath to obtain a apothegmatic regular unofficial of the stylish programme and analysts’ ratings for Novartis and attendant companies with MarketBeat.com’s FREE regular telecommunicate newsletter.